Abiomed Announces Q1 FY 2017 Revenue of $103.0 Million, Up 40% Over Prior Year
DANVERS, Mass., July 28, 2016 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2017 revenue of $103.0 million, an increase of 40% compared to revenue of $73. …